These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11366467)

  • 21. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp.
    Kessler H
    Posit Aware; 2007; 18(6):22-4. PubMed ID: 18074429
    [No Abstract]   [Full Text] [Related]  

  • 22. HE2000 AIDS drug shows promise in clinical trials.
    Senior K
    Mol Med Today; 2000 Sep; 6(9):333-4. PubMed ID: 10954862
    [No Abstract]   [Full Text] [Related]  

  • 23. Remune trial ended.
    Res Initiat Treat Action; 1999 Jul; 5(3):28. PubMed ID: 11366725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I; van der Horst C
    J HIV Ther; 2004 Sep; 9(3):65-8. PubMed ID: 15534564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABT-378 early access program begins.
    AIDS Treat News; 1999 Oct; (No 328):1-2. PubMed ID: 11366816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 reverse transcriptase inhibitors.
    El Safadi Y; Vivet-Boudou V; Marquet R
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese drug begins trials.
    AIDS Patient Care STDS; 2001 Apr; 15(4):226. PubMed ID: 11370651
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug watch.
    Whitson S
    Posit Aware; 1999; 10(4):18-9. PubMed ID: 11366796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V; Tebas P
    J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-1360 Shionogi-GlaxoSmithKline.
    Billich A
    Curr Opin Investig Drugs; 2003 Feb; 4(2):206-9. PubMed ID: 12669383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental drug treatment cost in HIV-positive patients in industry-sponsored clinical trials.
    Perrín RS; López FJ
    Ann Pharmacother; 2008 Nov; 42(11):1586-91. PubMed ID: 18780807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV clinical trials.
    Posit Living; 1999 Nov; 8(10):49-56. PubMed ID: 11367334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine+ddI+Hydroxyurea antiretroviral trial, AIDS Research Alliance, Los Angeles.
    AIDS Treat News; 1999 Dec; (No 332):8. PubMed ID: 11367131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New fixed-dose once-a-day starting regimens: interview with Cal Cohen, M.D. Interview by John S. James.
    Cohen C
    AIDS Treat News; 2004 Sep; (405):3-6. PubMed ID: 15595150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiretroviral therapy 2001. Basic principles and current status].
    Jablonowski H
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():4-12. PubMed ID: 11373777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
    Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.